NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis

NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis – Step-by-Step Guide

The first step before starting to write the NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis is to understand the requirements of the assignment. The first step is to read the assignment prompt carefully to identify the topic, the length and format requirements. You should go through the rubric provided so that you can understand what is needed to score the maximum points for each part of the assignment. 

It is also important to identify the paper’s audience and purpose, as this will help you determine the tone and style to use throughout. You can then create a timeline to help you complete each stage of the paper, such as conducting research, writing the paper, and revising it to avoid last-minute stress before the deadline. After identifying the formatting style to be applied to the paper, such as APA, review its use, including writing citations and referencing the resources used. You should also review the formatting requirements for the title page and headings in the paper, as outlined by Chamberlain University.

How to Research and Prepare for NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis

The next step in preparing for your paper is to conduct research and identify the best sources to use to support your arguments. Identify a list of keywords related to your topic using various combinations. The first step is to visit the Chamberlain University library and search through its database using the important keywords related to your topic. You can also find books, peer-reviewed articles, and credible sources for your topic from the Chamberlain University Library, PubMed, JSTOR, ScienceDirect, SpringerLink, and Google Scholar. Ensure that you select the references that have been published in the last 5 years and go through each to check for credibility. Ensure that you obtain the references in the required format, such as APA, so that you can save time when creating the final reference list. 

You can also group the references according to their themes that align with the outline of the paper. Go through each reference for its content and summarize the key concepts, arguments and findings for each source. You can write down your reflections on how each reference connects to the topic you are researching. After the above steps, you can develop a strong thesis that is clear, concise and arguable. Next, create a detailed outline of the paper to help you develop headings and subheadings for the content. Ensure that you plan what point will go into each paragraph.

How to Write the Introduction for NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis

The introduction of the paper is the most crucial part, as it helps provide the context of your work and determines whether the reader will be interested in reading through to the end. Begin with a hook, which will help capture the reader’s attention. You should contextualize the topic by offering the reader a concise overview of the topic you are writing about so that they may understand its importance. You should state what you aim to achieve with the paper. The last part of the introduction should be your thesis statement, which provides the main argument of the paper.

How to Write the Body for NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis

The body of the paper helps you to present your arguments and evidence to support your claims. You can use headings and subheadings developed in the paper’s outline to guide you on how to organize the body. Start each paragraph with a topic sentence to help the reader know what point you will be discussing in that paragraph. Support your claims using the evidence collected from the research, and ensure that you cite each source properly using in-text citations. You should analyze the evidence presented and explain its significance, as well as how it relates to the thesis statement. You should maintain a logical flow between paragraphs by using transition words and a flow of ideas.

How to Write the In-text Citations for NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis

In-text citations help readers give credit to the authors of the references they have used in their work. All ideas that have been borrowed from references, any statistics and direct quotes must be referenced properly. The name and date of publication of the paper should be included when writing an in-text citation. For example, in APA, after stating the information, you can put an in-text citation after the end of the sentence, such as (Smith, 2021). If you are quoting directly from a source, include the page number in the citation, for example (Smith, 2021, p. 15). Remember to also include a corresponding reference list at the end of your paper that provides full details of each source cited in your text. An example paragraph highlighting the use of in-text citations is as below:

“The integration of technology in nursing practice has significantly transformed patient care and improved health outcomes. According to Morelli et al. (2024), the use of electronic health records (EHRs) has streamlined communication among healthcare providers, allowing for more coordinated and efficient care delivery. Furthermore, Alawiye (2024) highlights that telehealth services have expanded access to care, particularly for patients in rural areas, thereby reducing barriers to treatment.”

How to Write the Conclusion for NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis

When writing the conclusion of the paper, start by restating your thesis, which helps remind the reader what your paper is about. Summarize the key points of the paper by restating them. Discuss the implications of your findings and your arguments. Conclude with a call to action that leaves a lasting impression on the reader or offers recommendations.

How to Format the Reference List for NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis

The reference helps provide the reader with the complete details of the sources you cited in the paper. The reference list should start with the title “References” on a new page. It should be aligned center and bolded. The references should be organized in an ascending order alphabetically, and each should have a hanging indent. If a source has no author, it should be alphabetized by the title of the work, ignoring any initial articles such as “A,” “An,” or “The.” If you have multiple works by the same author, list them in chronological order, starting with the earliest publication. 

Each reference entry should include specific elements depending on the type of source. For books, include the author’s last name, first initial, publication year in parentheses, the title of the book in italics, the edition (if applicable), and the publisher’s name. For journal articles, include the author’s last name, first initial, publication year in parentheses, the title of the article (not italicized), the title of the journal in italics, the volume number in italics, the issue number in parentheses (if applicable), and the page range of the article. For online sources, include the DOI (Digital Object Identifier) or the URL at the end of the reference. An example reference list is as follows:

References

Morelli, S., Daniele, C., D’Avenio, G., Grigioni, M., & Giansanti, D. (2024). Optimizing telehealth: Leveraging Key Performance Indicators for enhanced telehealth and digital healthcare outcomes (Telemechron Study). Healthcare, 12(13), 1319. https://doi.org/10.3390/healthcare12131319

Alawiye, T. (2024). The impact of digital technology on healthcare delivery and patient outcomes. E-Health Telecommunication Systems and Networks, 13, 13-22. 10.4236/etsn.2024.132002.

NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis Reflection Instructions

Reflection: Address the following questions:  

1. Which diagnostic tests did you select for this client? Using the estimated national average cost for each diagnostic test from a website such as MD save ///https://www.mdsave.com/ calculate the total cost for diagnostic testing for this client if he was uninsured. How might this information change your decision to order diagnostic tests for the client? 

1. Data indicate that clients with chronic lung disease and low income have increased utilization of acute care services (Melillo, 2021).
2. What questions should the primary provider ask when providing education to clients with these diagnoses to ensure they have the resources they need to follow up with appropriate care?

·  Include the following components: 

1. write 150-300 words in a Microsoft Word document 
2. demonstrate clinical judgment appropriate to the virtual patient scenario
3. cite at least one relevant scholarly source as defined by program expectations
4. communicate with minimal errors in English grammar, spelling, syntax, and punctuation 

J.C. is a 66-year-old who presents with complaints of worsening SOB and cough. The onset of symptoms was approximately 10 years ago, but they have become progressively worse in the last 5 years. PMH pertinent for HTN, D.M. (controlled), and Seasonal allergies. He is a 40-pack-year former smoker with a known occupational history of asbestos exposure. He reports associated symptoms of wheezing, persistent productive cough (thick white sputum) that is worse at night, bilateral pedal edema, increased fatigue, and worsening exertional dyspnea.

States his SOB is now impacting his functional ability and QOL. He denies C.P., palpitations, syncope, dizziness, numbness, recent illness, and exposure to sick contact. No recent travel. Denies fever/ chills, H.A., numbness/ tingling, and GI/GU symptoms. Patient is afebrile on arrival with O2 saturation 94% on R.A. at rest. B.P. elevated. Exam reveals increased work of breathing with accessory muscle use and persistent cough. No hyperresonance or evidence of hyperinflation or clubbing is noted, but he exhibits bilateral wheezing and diffuse crackles. HR regular with Mitral valve regurgitation noted on auscultation. There is a family hx significant for heart disease, his brother is deceased from CA.

DX: COPD moderate with possible 2^nd to allergic asthma

NR603 Week 3 iHuman Case Study: Respiratory Symptom Analysis Reflection Example

Balancing Healthcare Costs and Diagnostic Testing for Patients with Chronic Lung Disease

Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and allergic asthma, present significant challenges for both patients and healthcare providers. Alongside managing symptoms and preventing exacerbations, accurate diagnosis through diagnostic testing plays a crucial role in effective disease management (Lin et al., 2023). However, the cost of diagnostic tests can pose a barrier to access, particularly for individuals with low incomes and limited insurance coverage.

When assessing a patient with suspected or established chronic lung disease, healthcare providers must determine which diagnostic tests are essential for accurate diagnosis and effective management. Tests such as arterial blood gas (ABG), bronchoscopy, methacholine challenge, pulmonary function test (PFT), and chest X-ray are commonly used to evaluate lung function, assess disease severity, and identify underlying conditions. However, each of these tests comes with a significant financial cost, which can be prohibitive for uninsured or underinsured patients.

In the scenario presented, a patient with moderate COPD and possible secondhand allergic asthma requires several diagnostic tests to confirm the diagnosis and guide treatment decisions. The estimated total cost of these tests without insurance is substantial, showing the financial burden that diagnostic testing can impose on patients with chronic lung disease. In addition, research suggests that individuals with chronic lung disease and low income are more likely to utilize acute care services, indicating a potential correlation between financial barriers and healthcare utilization patterns.

The diagnostic tests and their costs according to the national estimates: Arterial blood gas (ABG): $489, Bronchoscopy: $1848, Methacholine challenge: $2584, Pulmonary function test (PFT): $884, X-ray chest PA and lateral: $279. Total cost without insurance: $6084.

Considering the patient’s diagnosis of moderate COPD with possible secondhand allergic asthma and the fact that clients with chronic lung disease and low income tend to utilize acute care services more frequently, cost can be a significant barrier to accessing necessary diagnostic tests. The primary provider might need to consider the necessity of each test, balancing diagnostic accuracy with cost-effectiveness. Questions the primary provider should ask when providing education to such clients to ensure they have the resources they need to follow up with appropriate care include:

1. Do you have health insurance coverage that can assist with the cost of diagnostic tests and treatments?
2. Are you aware of any financial assistance programs or community resources available to help cover medical expenses?
3. Do you have a support system in place to help you manage your chronic lung disease and navigate the healthcare system?

By addressing these questions, the primary provider can better understand the patient’s specific needs and circumstances, ensuring they receive the necessary support to access and follow up with appropriate care. Given the high cost of diagnostic testing and the socioeconomic factors influencing healthcare utilization, healthcare providers must exercise clinical judgment when ordering tests for patients with chronic lung disease. While comprehensive diagnostic evaluation is essential for optimal patient care, providers must balance the need for diagnostic accuracy with the financial implications for the patient (AbdulRaheem, 2023). This requires careful consideration of the clinical utility of each test, weighing the potential benefits against the costs and potential adverse effects on the patient’s financial well-being.

In addition to clinical considerations, providers must also address the broader socioeconomic context in which patients with chronic lung disease navigate the healthcare system. Providing education and support to ensure patients have access to resources such as health insurance coverage, financial assistance programs, transportation, and social support networks is essential for mitigating barriers to care (McMaughan et al., 2020). By addressing these factors, providers can empower patients to actively participate in their healthcare and access the necessary diagnostic testing and treatments.

References

AbdulRaheem, Y. (2023). Unveiling the significance and challenges of integrating prevention levels in healthcare practice. Journal of Primary Care & Community Health, 14. https://doi.org/10.1177/21501319231186500

Lin, C.-H., Cheng, S.-L., Chen, C.-Z., Chen, C.-H., Lin, S.-H., & Wang, H.-C. (2023). Current progress of COPD early detection: Key points and novel strategies. International Journal of Chronic Obstructive Pulmonary Disease, 18, 1511–1524. https://doi.org/10.2147/copd.s413969

McMaughan, D. J., Oloruntoba, O., & Smith, M. L. (2020). Socioeconomic status and access to healthcare: Interrelated drivers for healthy aging. Frontiers in Public Health, 8. https://doi.org/10.3389/fpubh.2020.00231